weight;word
2165;patients
1158;model
1026;patient
981;groups
882;brain
816;control group
578;group
534;population
478;participants
460;cells
442;two groups
442;healthy controls
436;sample
415;children
401;region
368;trial
366;cases
352;study
336;hippocampus
336;models
316;system
310;individuals
302;vaccine
291;literature
284;field
282;subjects
278;older adults
274;regions
269;general population
268;pregnant women
260;environment
256;brain regions
244;child
236;cohort
216;framework
210;genes
204;elderly
198;areas
194;samples
194;healthy volunteers
194;task
192;animals
188;countries
188;healthy subjects
186;FundingBill & Melinda Gates Foundation
186;Medical Research Council
185;sub-Saharan Africa
180;young people
174;area
172;animal models
170;questionnaire
168;tumor
168;species
166;compounds
166;intervention group
160;human brain
160;hospital
156;placebo group
150;Wellcome Trust
150;vaccines
150;assay
150;stimulus
144;drugs
144;control subjects
144;stimuli
142;e-cigarettes
142;women
142;drug
140;lesion
140;healthy individuals
140;network
140;protein
138;body
136;age group
136;individual
134;three groups
132;community
130;case
130;subject
126;Bill & Melinda Gates Foundation
126;older people
126;study group
126;tool
124;cortex
122;people
122;young adults
120;world
120;lesions
120;proteins
120;age groups
118;virus
118;country
116;hearing aids
114;young children
114;amygdala
114;site
114;data
112;FundingWellcome Trust
112;high-income countries
112;participant
110;structures
110;white matter
110;studies
108;liver
108;brain areas
108;clinic
108;pathway
108;context
106;sexes
106;healthy participants
104;gene
104;mice
104;developing countries
102;populations
102;PD patients
102;central nervous system
102;immune system
100;object
100;low- and middle-income countries
98;setting
96;[1].
96;ears
96;one patient
96;cerebellum
96;systems
94;infants
94;receptors
94;mouse model
92;low-income and middle-income countries
92;two patients
92;who
90;software
90;UK
90;striatum
88;networks
86;elderly patients
86;spinal cord
86;visual cortex
86;compound
86;face
84;low-income countries
84;receptor
84;healthy adults
82;genders
82;thalamus
82;pathways
82;dataset
80;retrospective study
80;rats
80;treatment groups
80;adult patients
80;tumors
80;family
78;database
78;target
78;link
78;consecutive patients
76;disease
76;assays
76;nucleus
76;healthy control subjects
76;enzyme
76;animal
76;series
74;heart
74;rural areas
74;neurons
74;tissue
74;hand
72;parents
72;prefrontal cortex
72;CNS
72;test
72;endothelial cells
70;viruses
70;skin
70;mother
70;plasma membrane
70;primary care
70;tasks
70;set
68;Ca2+
68;cell
68;treatment group
68;DMPA-SC
68;products
68;associations
68;tools
66;allergic rhinitis
66;auditory system
66;grey matter
66;retina
66;health care
66;domain
66;settings
64;nasal polyps
64;cochlea
64;experimental group
64;causes
64;UK Medical Research Council
64;mothers
64;cell lines
64;components
64;items
64;control groups
64;strains
64;postmenopausal women
62;mass
62;otoacoustic emissions
62;prospective study
62;surgeon
62;parasite
62;basal ganglia
62;structure
62;scene
60;otitis media
60;air pollution
60;device
60;children and adolescents
60;sites
60;age-matched controls
59;images
58;MenACWY-TT
58;genome
58;host
58;blood samples
58;eye
58;health facilities
58;simulations
58;domains
58;nervous system
58;association
58;study population
56;vocal folds
56;isolates
56;guinea pigs
56;patient group
56;Cancer Research UK
56;stem cells
56;four groups
56;2 groups
56;health systems
56;molecules
56;visual stimuli
56;brain networks
56;matched controls
56;devices
56;adipose tissue
56;signal
54;health services
54;cell types
54;20 patients
54;combination
54;survey
54;control participants
54;patient groups
54;platform
54;mouse
54;organism
52;institution
52;cohorts
52;antibodies
52;motor cortex
52;genetic variants
52;working memory
52;instrument
52;signals
52;visual system
50;oral cavity
50;nasal cavity
50;pathogens
50;men and women
50;fMRI data
50;perirhinal cortex
50;tissues
50;urban areas
50;agent
50;immune cells
50;auditory cortex
50;cortical regions
50;Blood samples
50;mouse models
50;person
50;self
50;technology
50;hypothesis
50;diet
50;placenta
48;larynx
48;ear
48;British Heart Foundation
48;pathogen
48;cancers
48;CT scans
48;observational studies
48;study groups
48;three patients
48;articles
48;brainstem
48;clinical setting
48;2 patients
48;different populations
48;group of patients
48;controls
46;Brazilian Portuguese
46;new vaccines
46;intention-to-treat population
46;prostate cancer
46;UK Biobank
46;datasets
46;α-synuclein
46;dopaminergic neurons
46;cell line
46;mast cells
46;laboratory
46;preterm infants
46;study participants
46;emergency department
44;iPSC line
44;left ear
44;neural circuits
44;code
44;breast cancer
44;& Melinda Gates Foundation
44;computational models
44;conceptual framework
44;Wistar rats
44;membrane
44;case study
44;topic
44;default mode network
44;five patients
44;sequence
44;individual patients
44;agents
44;frontal cortex
44;functional connectivity
44;usual care
44;paradigm
44;clinical trials
44;low-resource settings
42;plants
42;right ear
42;embryo
42;tumour
42;states
42;list
42;elderly people
42;Research UK
42;ISRCTN registry
42;small molecules
42;pediatric patients
42;subset
42;vasculature
42;whole brain
42;AD patients
42;subgroup
42;families
42;cancer patients
42;location
40;middle ear
40;[2].
40;head and neck
40;vitro assays
40;project
40;female patients
40;infected cells
40;deprived areas
40;day
40;cortical areas
40;interface
40;6 patients
40;health system
40;elderly subjects
40;reactive oxygen species
40;infant
40;rat
40;corpus callosum
40;substrate
40;animal model
40;older patients
40;observer
40;Parents and Children
38;maxillary sinus
38;chronic otitis media
38;nose
38;grid cells
38;lymph nodes
38;USA
38;younger patients
38;birth cohort
38;many countries
38;dog
38;joint
38;tests
38;scanner
38;left hemisphere
38;motor system
38;word
38;elements
38;rodent models
38;gut microbiota
38;BBB
38;targets
38;transgenic mice
38;theory
38;latter
38;control mice
36;animal product-free environment
36;γ-irradiated human foreskin fibroblasts
36;laser microsurgery
36;ICM
36;foreign body
36;cochlear implants
36;cochlear implant
36;new technologies
36;cohort study
36;male patients
36;cancer cells
36;many patients
36;clinical settings
36;12 patients
36;four patients
36;mathematical model
36;3 patients
36;complex
36;Americas
36;hypothalamus
36;neuronal populations
36;material
36;patients with schizophrenia
36;Two patients
36;review
36;electronic databases
36;sequences
36;future
36;signaling pathways
36;brain tissue
36;dopamine neurons
36;ventral striatum
36;woman
36;variables
36;Internet
36;conditions
36;offspring
36;patients with COPD
36;objects
36;head
36;eyes
34;[4].
34;soil
34;inner ear
34;Streptococcus pneumoniae
34;S. aureus
34;product
34;indoor residual spraying
34;per-protocol population
34;men
34;National Institute
34;organs
34;18 patients
34;BOLD signal
34;emotional faces
34;mental health services
34;breast
34;young women
34;developed countries
34;strain
34;mammalian cells
34;blood
34;intestine
34;developing brain
34;gastrointestinal tract
34;lung
34;normal controls
34;stroke patients
34;non-human primates
34;STN
34;epithelium
34;bacteria
34;biomarker
34;therapeutic target
34;intrusive memories
34;caregivers
34;One patient
34;cues
34;condition
34;drinking water
34;skeletal muscle
34;normal subjects
32;occupational noise
32;head and neck cancer
32;50 patients
32;thyroid gland
32;home
32;placebo recipients
32;mobile phones
32;respondents
32;current smokers
32;source